Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran
Authors:
- Joanne van RynJRJoanne van Ryn
- Lawrence BaruchLBLawrence Baruch
- Andreas ClemensACAndreas Clemens
- 1 April 2012
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 125 (4) , 417-420
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Dabigatran Falsely Elevates Point of Care International Normalized Ratio ResultsThe American Journal of Medicine, 2011
- Potential Inaccuracy of Point-of-Care INR in Dabigatran-Treated PatientsAnnals of Pharmacotherapy, 2011
- Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activityThrombosis and Haemostasis, 2010